Evidence map›Paper›PMID 31766559›Full record

ArticleNanomaterials (Basel, Switzerland)2019

Plasma Surface Polymerized and Biomarker Conjugated Boron Nitride Nanoparticles for Cancer-Specific Therapy: Experimental and Theoretical Study.

Elizaveta S Permyakova, Liubov Yu Antipina, Philipp V Kiryukhantsev-Korneev, Andrey M Kovalskii, Josef Polčak, Anton Manakhov, Kristina Yu Gudz, Pavel B Sorokin, Dmitry V Shtansky

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Biodegradable and Peroxidase-Mimetic Boron Oxynitride Nanozyme for Breast Cancer Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Elizaveta S PermyakovaNational University of Science and Technology "MISIS", Leninsky prospect 4, 119049 Moscow, Russia.ORCID 0000-0003-2581-0803
Liubov Yu AntipinaNational University of Science and Technology "MISIS", Leninsky prospect 4, 119049 Moscow, Russia.ORCID 0000-0003-1176-317X
Philipp V Kiryukhantsev-KorneevNational University of Science and Technology "MISIS", Leninsky prospect 4, 119049 Moscow, Russia.ORCID 0000-0003-1635-4746
Andrey M KovalskiiNational University of Science and Technology "MISIS", Leninsky prospect 4, 119049 Moscow, Russia.
Josef PolčakCEITEC-Central European Institute of Technology, Brno University of Technology, Technická 3058/10, 61600 Brno, Czech Republic.ORCID 0000-0002-6571-6291
Anton ManakhovNational University of Science and Technology "MISIS", Leninsky prospect 4, 119049 Moscow, Russia.
Kristina Yu GudzNational University of Science and Technology "MISIS", Leninsky prospect 4, 119049 Moscow, Russia.ORCID 0000-0002-8990-9784
Pavel B SorokinNational University of Science and Technology "MISIS", Leninsky prospect 4, 119049 Moscow, Russia.ORCID 0000-0001-5248-1799
Dmitry V ShtanskyNational University of Science and Technology "MISIS", Leninsky prospect 4, 119049 Moscow, Russia.
National University of Science and Technology · RUCentral European Institute of Technology · CZ

Funding

Ministry of Education and Science of the Russian Federation K2-2018-012 and K2А-2018-038
6 · The paper itself

Abstract

A new low-pressure plasma-based approach to activate the surface of BN nanoparticles (BNNPs) in order to facilitate the attachment of folate acid (FA) molecules for cancer-specific therapy is described. Plasma treatment of BNNPs (BNNPs

Indexed as

BN nanoparticleschemical vapor depositiondensity functional theorydrug delivery nanocarriersfolic acid conjugatesplasma surface polymerization

Identifiers

PMID31766559
PMCPMC6956006
OpenAlexW2990508880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.